recurrent bladder cancer
Showing 1 - 21 of 21
Distal Urethral Cancer, Proximal Urethral Cancer, Recurrent Bladder Cancer Trial in United States (afatinib dimaleate,
Recruiting
- Distal Urethral Cancer
- +8 more
- afatinib dimaleate
- laboratory biomarker analysis
-
Atlanta, Georgia
- +5 more
Sep 24, 2021
Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in
Completed
- Distal Urethral Cancer
- +10 more
- Gemcitabine hydrochloride
- +3 more
-
Springfield, Missouri
- +1 more
Sep 17, 2020
Recurrent Bladder Cancer, Transitional Cell Carcinoma of the Bladder Trial in Cleveland (sunitinib malate, immunohistochemistry
Terminated
- Recurrent Bladder Cancer
- Transitional Cell Carcinoma of the Bladder
- sunitinib malate
- +4 more
-
Cleveland, Ohio
- +1 more
Apr 17, 2019
Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer
Completed
- Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
- +6 more
- sorafenib tosylate
- laboratory biomarker analysis
-
Toronto, Ontario, CanadaPrincess Margaret Hospital Phase 2 Consortium
Jul 26, 2018
Recurrent Bladder Cancer, Stage III Bladder Cancer, Stage IV Bladder Cancer Trial in Los Angeles (drug, other, genetic)
Terminated
- Recurrent Bladder Cancer
- +3 more
- docetaxel
- +4 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center
May 10, 2018
Recurrent Bladder Cancer, Stage 0 Bladder Cancer, Stage I Bladder Cancer Trial in Buffalo (broccoli sprout extract, laboratory
Terminated
- Recurrent Bladder Cancer
- +4 more
- broccoli sprout extract
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
May 31, 2017
Bladder Cancer, Disease Progression, Recurrent Bladder Cancer Trial (Intravesical BCG instillation)
Completed
- Bladder Cancer
- +2 more
- Intravesical BCG instillation
- (no location specified)
May 31, 2017
Recurrent Bladder Cancer, Stage IV Bladder Cancer, Transitional Cell Carcinoma of the Bladder Trial in Belgium, France
Completed
- Recurrent Bladder Cancer
- +2 more
- Trastuzumab
- +3 more
-
Bruxelles, Belgium
- +14 more
Feb 3, 2017
Recurrent Bladder Cancer, Stage 0 Bladder Cancer, Stage I Bladder Cancer Trial (robot-assisted laparoscopic surgery,
Withdrawn
- Recurrent Bladder Cancer
- +4 more
- robot-assisted laparoscopic surgery
- +2 more
- (no location specified)
Nov 8, 2016
Adenocarcinoma of the Bladder, Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter Trial
Terminated
- Adenocarcinoma of the Bladder
- +12 more
- sorafenib tosylate
- laboratory biomarker analysis
-
Boston, MassachusettsEastern Cooperative Oncology Group
May 20, 2014
Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer
Completed
- Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
- +9 more
-
San Francisco, CaliforniaUCSF-Mount Zion
Jun 4, 2013
Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in
Terminated
- Distal Urethral Cancer
- +8 more
- trastuzumab
-
Chicago, IllinoisCancer and Leukemia Group B
May 1, 2013
Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,
Completed
- Advanced Adult Primary Liver Cancer
- +126 more
- recombinant interleukin-12
- ABI-007/carboplatin/trastuzumab
-
Columbus, OhioOhio State University Medical Center
Feb 27, 2013
Recurrent Bladder Cancer Trial in Houston (celecoxib, )
Completed
- Recurrent Bladder Cancer
- celecoxib
- placebo
-
Houston, TexasM D Anderson Cancer Center
Feb 12, 2013
Male Breast Cancer, Recurrent Bladder Cancer, Recurrent Breast Cancer Trial in Los Angeles (decitabine, pharmacological study,
Completed
- Male Breast Cancer
- +8 more
- decitabine
- +2 more
-
Los Angeles, CaliforniaUniversity of Southern California
Feb 6, 2013
Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in
Completed
- Distal Urethral Cancer
- +10 more
-
Boston, MassachusettsEastern Cooperative Oncology Group
Jan 23, 2013
Recurrent Bladder Cancer, Stage I Bladder Cancer, Stage II Bladder Cancer Trial in Houston (Ad5CMV-p53 gene)
Completed
- Recurrent Bladder Cancer
- +5 more
- Ad5CMV-p53 gene
-
Houston, TexasM D Anderson Cancer Center
Jan 22, 2013
Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Chicago (erlotinib HCl,
Completed
- Adult Anaplastic Astrocytoma
- +85 more
- erlotinib hydrochloride
- laboratory biomarker analysis
-
Chicago, IllinoisCancer and Leukemia Group B
Jan 15, 2013
Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer
Completed
- Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
- +5 more
- trastuzumab
- +4 more
-
Ann Arbor, MichiganUniversity of Michigan University Hospital
Jan 11, 2013